{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:36:29Z","timestamp":1785796589677,"version":"3.56.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100024172","name":"Schleswig-Holstein","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100024172","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.atherosclerosis.2026.120801","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:19:20Z","timestamp":1780589960000},"page":"120801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pyoderma gangrenosum is associated with excess incident major atherothrombotic events"],"prefix":"10.1016","volume":"418","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6430-0252","authenticated-orcid":false,"given":"Hatim","family":"Kerniss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Olbrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Curman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"St\u00e4nder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalaf","family":"Kridin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Leistner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf J.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2026.120801_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.118541","article-title":"Genetic and epigenetic regulation of inflammasomes: role in atherosclerosis","volume":"396","author":"Yalcinkaya","year":"2024","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120801_bib2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.atherosclerosis.2009.09.075","article-title":"Toll like receptor 4 in atherosclerosis and plaque destabilization","volume":"209","author":"den Dekker","year":"2010","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120801_bib3","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/CIRCRESAHA.116.309692","article-title":"Neutrophil extracellular traps in atherosclerosis and atherothrombosis","volume":"120","author":"D\u00f6ring","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2026.120801_bib4","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"34","key":"10.1016\/j.atherosclerosis.2026.120801_bib5","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120801_bib6","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jid.2024.12.023","article-title":"The changing landscape of clinical research in pyoderma gangrenosum","volume":"145","author":"Becker","year":"2025","journal-title":"J Invest Dermatol"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120801_bib7","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/ATVBAHA.119.312463","article-title":"Neutrophil extracellular traps: Villains and targets in arterial, venous, and cancer-associated thrombosis","volume":"39","author":"Th\u00e5lin","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2026.120801_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2019.06.919","article-title":"The pathway of neutrophil extracellular traps towards atherosclerosis and thrombosis","volume":"288","author":"Moschonas","year":"2019","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120801_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jamadermatol.2022.5437","article-title":"Association of all-cause and cause-specific mortality risks with pyoderma gangrenosum","volume":"159","author":"Lee","year":"2023","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120801_bib10","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1111\/jdv.18527","article-title":"Risk of cardiovascular diseases in pyoderma gangrenosum: a population-based study","volume":"37","author":"Shavit","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.atherosclerosis.2026.120801_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/jvc2.70114","article-title":"Pyoderma gangrenosum associated with major adverse cardiovascular events","author":"Adjei-Frimpong","year":"2025","journal-title":"JEADV Clin Pract"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120801_bib12","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1161\/CIRCRESAHA.116.304944","article-title":"Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size","volume":"116","author":"Mangold","year":"2015","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120801_bib13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ana.24993","article-title":"Neutrophil extracellular traps in ischemic stroke thrombi","volume":"82","author":"Laridan","year":"2017","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120801_bib14","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/STROKEAHA.117.019896","article-title":"Thrombus neutrophil extracellular traps content impair tPA-induced thrombolysis in acute ischemic stroke","volume":"49","author":"Ducroux","year":"2018","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120801_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00395-019-0740-3","article-title":"Neutrophil extracellular traps and fibrocytes in ST-segment elevation myocardial infarction","volume":"114","author":"Hofbauer","year":"2019","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120801_bib16","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1194\/jlr.M004085","article-title":"Oxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export","volume":"51","author":"Shao","year":"2010","journal-title":"J Lipid Res"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.120801_bib17","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1161\/CIRCRESAHA.114.303454","article-title":"Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase","volume":"114","author":"Shao","year":"2014","journal-title":"Circ Res"},{"issue":"15","key":"10.1016\/j.atherosclerosis.2026.120801_bib18","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.3390\/cells11152288","article-title":"Neutrophil elastase increases vascular permeability and leukocyte transmigration in cultured endothelial cells and obese mice","volume":"11","author":"Ushakumari","year":"2022","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120801_bib19","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1161\/CIRCRESAHA.118.311362","article-title":"NLRP3 inflammasome and the IL-1 pathway in atherosclerosis","volume":"122","author":"Grebe","year":"2018","journal-title":"Circ Res"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120801_bib20","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"CANTOS trial group. Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2026.120801_bib21","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1161\/CIRCULATIONAHA.118.038010","article-title":"Anti-Inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure","author":"Everett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2026.120801_bib22","doi-asserted-by":"crossref","DOI":"10.1177\/17534259231189195","article-title":"Role of neutrophils in different stages of atherosclerosis","author":"Zhang","year":"2023","journal-title":"Innate Immun"},{"key":"10.1016\/j.atherosclerosis.2026.120801_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1516126","article-title":"A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX","volume":"16","author":"Ludwig","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2026.120801_bib24","article-title":"Inflammation and atherosclerosis: signaling pathways and therapeutic intervention","volume":"131","author":"Kong","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"23","key":"10.1016\/j.atherosclerosis.2026.120801_bib25","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","article-title":"Inflammation in atherosclerosis: from pathophysiology to practice","volume":"54","author":"Libby","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.atherosclerosis.2026.120801_bib26","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa035003","article-title":"Prognostic value of myeloperoxidase in patients with chest pain","volume":"349","author":"Brennan","year":"2003","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120801_bib27","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/01.ATV.0000163262.83456.6d","article-title":"Myeloperoxidase and cardiovascular disease","volume":"25","author":"Nicholls","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"25","key":"10.1016\/j.atherosclerosis.2026.120801_bib28","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American college of cardiology\/American Heart Association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2026.120801_bib29","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.atherosclerosis.2018.05.001","article-title":"Evaluation of coronary features of HIV patients presenting with ACS: the CUORE, a multicenter study","volume":"274","author":"Peyracchia","year":"2018","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120801_bib30","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s40257-018-0356-7","article-title":"Underlying systemic diseases in pyoderma gangrenosum: a systematic review and meta-analysis","author":"Kridin","year":"2018","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120801_bib31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120801_bib32","doi-asserted-by":"crossref","first-page":"e1003432","DOI":"10.1371\/journal.pmed.1003432","article-title":"Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study","volume":"17","author":"Pujades-Rodriguez","year":"2020","journal-title":"PLOS Med"},{"issue":"14","key":"10.1016\/j.atherosclerosis.2026.120801_bib33","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.jacc.2022.07.006","article-title":"2022 ACC expert consensus decision pathway on nonstatin therapies for LDL-C lowering in the management of atherosclerotic cardiovascular disease risk: a report of the american college of cardiology solution set oversight committee","volume":"80","author":"Lloyd-Jones","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120801_bib34","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001251","article-title":"2024 AHA\/ACC guideline for the management of lower extremity peripheral artery disease","author":"Gornik","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2026.120801_bib35","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/bjd.14037","article-title":"Canakinumab in adults with steroid\u2010refractory pyoderma gangrenosum","volume":"173","author":"Kolios","year":"2015","journal-title":"Br J Dermatol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120801_bib36","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1159\/000519320","article-title":"Pyoderma gangrenosum and interleukin inhibitors: a semi-systematic review","volume":"238","author":"Ben Abdallah","year":"2022","journal-title":"Dermatology"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191502600167X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191502600167X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T01:00:49Z","timestamp":1782176449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191502600167X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":36,"alternative-id":["S002191502600167X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120801","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyoderma gangrenosum is associated with excess incident major atherothrombotic events","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120801","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120801"}}